Here are five quick notes on the rating:
1. The BBB+ rating indicates Zimmer is at moderate default risk.
2. Morningstar gave Zimmer stock a four-star rating.
3. Oppenheimer reiterated an “outperform” rating and issued $124 price target on shares in May.
4. Shares opened at $101.73 on Monday.
5. Zimmer has a market cap at $17.33 billion.
More articles on orthopedic devices:
5 key notes on Invuity’s new CFO
TC Orthopedics demonstrates MAKO technology
Global sports medicine market to reach $53.6B by 2022
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
